grant

Identifying intervention opportunities in the continuum of cognitive impairment among persons aging with HIV

Organization JOHNS HOPKINS UNIVERSITYLocation BALTIMORE, UNITED STATESPosted 2 Feb 2026Deadline 1 Feb 2027
NIHUS FederalResearch GrantFY2026AIDS VirusAIDS dementiaAIDS preventionAIDS with dementiaAIDS-related dementiaAcquired Immune Deficiency Syndrome VirusAcquired Immune Deficiency Syndrome related dementiaAcquired Immunodeficiency Syndrome VirusAddressAdherenceAdverse effectsAgeAgingAlcohol abuseAttentionBehavioralCNS Nervous SystemCentral Nervous SystemClinicalClinical DataCognitiveCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive function abnormalCohort StudiesCross-Product RatioDataDementia Due to HIV DiseaseDementia associated with AIDSDementia in human immunodeficiency virus (HIV) diseaseDevelopmentDisturbance in cognitionEpidemicEpidemiologistEpidemiologyEtOH abuseFaceGoalsHIVHIV DementiaHIV InfectionsHIV PreventionHIV and agingHIV associated agingHIV associated dementiaHIV diagnosisHIV disease transmissionHIV incidenceHIV individualsHIV infected individualsHIV infected menHIV infected personsHIV infection spreadHIV infection transmissionHIV peopleHIV positive individualsHIV positive menHIV positive peopleHIV related agingHIV replicationHIV spreadHIV transmissionHIV viral infectionHIV viral replicationHIV viral transmissionHIV virus infectionHIV+ menHIV-1 associated dementiaHIV-1 dementiaHIV-1 incidenceHIV-1 infectionHIV-1 infection incidenceHIV-1 preventionHIV-1 replicationHIV-1 spreadHIV-1 transmissionHIV-1 viral replicationHIV-1 virus replicationHIV-1 virus transmissionHIV-related dementiaHIV/AIDS incidenceHIV/AIDS preventionHIV/AIDS transmissionHealthHealth CareHuman Immunodeficiency Virus Type 1 transmissionHuman Immunodeficiency VirusesImpaired cognitionIncrease lifespanInfection by HIV-1Infection from HIV-1Infection of HIV-1InjuryInterventionLAV-HTLV-IIILinkLong-Term EffectsLymphadenopathy-Associated VirusMaintenanceMales living with HIVMemoryMen with HIVMental DepressionMentorshipMethodsNIH Office of AIDS ResearchNeuraxisNeurocognitiveOdds RatioPLWHPWHPersonsPh D studentPh D. studentPh. D. studentPh.D studentPh.D. studentPhD studentPhD. studentPopulationPopulation Attributable RisksPreparationPrevent HIVPreventative strategyPreventionPrevention strategyPreventive strategyPublic Health SchoolsQOLQuality of lifeRelative OddsResearchRiskRisk EstimateRisk FactorsRisk RatioRoleSmokingThe Multi-center AIDS Cohort StudyThe Multicenter AIDS Cohort StudyTimeTrainingViralViremiaVirusVirus-HIVWorkadverse consequenceadverse outcomeage associatedage correlatedage dependentage linkedage relatedage specificagesaging people with HIVaging population with HIVaging with HIVaging with human immunodeficiency virusalcohol co-abusealcohol problemantiretroviral therapyantiretroviral treatmentattributable fractionboost longevityco-morbidco-morbiditycognitive dysfunctioncognitive functioncognitive losscohortcohort research studycohort surveycomorbiditycompeting riskdepressiondesigndesigningdevelopmentaldoctoral studenteffective therapyeffective treatmentelongating the lifespanenhance longevityepidemiologicepidemiologicalethanol abuseexecutive controlexecutive functionexperienceextend life spanextend lifespanextend longevityfacesfacialfoster longevityhazardous alcohol usehuman immunodeficiency virus incidencehuman immunodeficiency virus infectionhuman immunodeficiency virus replicationhuman immunodeficiency virus transmissionhuman immunodeficiency virus-1 replicationimprove lifespanimprove longevityimprovedindividuals infected with HIVindividuals with HIVindividuals with human immunodeficiency virusinfected with HIVinfected with human immunodeficiency virusinjurieslifespan extensionman living with HIVmeetingmeetingsmen diagnosed with HIVmen infected with HIVmen living with HIVneural inflammationneuroinflammationneuroinflammatoryold agepeople infected with HIVpeople infected with human immunodeficiency viruspeople living with HIVpeople with HIVpeople with human immunodeficiency viruspreparationspreventprevent AIDSprevent human immunodeficiency viruspreventingproblem alcohol useproblem drinkingproblematic alcohol consumptionproblematic alcohol useprolong lifespanprolong longevitypromote lifespanpromote longevitypsychosocialrisk mitigationscreeningscreeningssocial rolespread of human immunodeficiency virussubstance usesubstance usingsupport longevityviraemiaviral sepsisvirusemiawhite matter damage
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY / ABSTRACT
Specific Aims: This proposal aims to identify opportunities to improve the prevention and mitigation of risks

associated with cognitive impairment among people aging with HIV. Aim 1 will estimate the proportion of

cognitive impairment cases potentially attributable to psychosocial and behavioral risk factors to prioritize

those, which if intervened upon, could hypothetically result in the greatest prevention of cognitive impairment.

Aim 2 will determine whether cognitive impairment increases the risk of losing one’s durable (sustained) viral

suppression so we may mitigate this adverse outcome.

Significance: As people with HIV (PWH) live longer due to treatment advances, they face a growing burden of

age-related conditions, including cognitive impairment. PWH experience higher rates of cognitive impairment

than people without HIV despite widespread viral suppression, which implicates non-HIV-related factors in their

cognitive risk. Focusing on psychosocial and behavioral risk factors, which are prevalent in PWH and causally

linked to cognitive impairment, can help to prioritize fruitful prevention strategies. In addition, cognitive

impairment may threaten the durability of viral suppression, which could hinder cognitive maintenance and

prevention of HIV transmission. Considering these issues in tandem can inform preparations for the long-term

healthcare needs of people aging with HIV.

Approach: These aims will leverage the Multicenter AIDS Cohort Study (MACS) (Aim 1), which includes 10

years of longitudinal cognitive screening data, and the Johns Hopkins HIV Clinical Cohort (JHHCC) (Aim 2), an

urban cohort of PWH with rich clinical data. In Aim 1, we will estimate population attributable fractions for

incident cognitive impairment, using longitudinal data and methods to account for time-varying risk factors,

censoring, and competing risks. In Aim 2, we will employ a longitudinal closed cohort design to estimate the

risk ratio for loss of durable viral suppression in PWH by cognitive impairment status.

Training Information: The proposed research encompasses the dissertation of Madeline Brooks, a PhD

student in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. The

training plan consists of coursework, mentorship, and professional development to support the successful

completion of these aims and prepare Ms. Brooks to become an independent research epidemiologist. These

aims address priorities of the NIH Office of AIDS Research to address the role of non-infectious comorbidities

in central nervous system complications and subsequent implications for HIV transmission.

Grant Number: 1F31MH142332-01
NIH Institute/Center: NIH

Principal Investigator: Madeline Brooks

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →